Testing effectiveness (Phase 2)Ended earlyNCT01189240
What this trial is testing
RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 13